Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Goodwill: 2018-2025

  • Dr Reddys Laboratories' Goodwill rose 170.59% to $138.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $138.0 million, marking a year-over-year increase of 170.59%. This contributed to the annual value of $138.0 million for FY2025, which is 170.59% up from last year.
  • Dr Reddys Laboratories' Goodwill amounted to $138.0 million in Q1 2025, which was up 170.59% from $51.0 million recorded in Q1 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Goodwill peaked at $138.0 million during Q1 2025, and registered a low of $51.0 million during Q1 2024.
  • Moreover, its 3-year median value for Goodwill was $52.0 million (2023), whereas its average is $80.3 million.
  • In the last 5 years, Dr Reddys Laboratories' Goodwill dropped by 10.34% in 2023 and then soared by 170.59% in 2025.
  • Quarterly analysis of 5 years shows Dr Reddys Laboratories' Goodwill stood at $62.0 million in 2021, then decreased by 6.45% to $58.0 million in 2022, then declined by 10.34% to $52.0 million in 2023, then declined by 1.92% to $51.0 million in 2024, then soared by 170.59% to $138.0 million in 2025.
  • Its last three reported values are $138.0 million in Q1 2025, $51.0 million for Q1 2024, and $52.0 million during Q1 2023.